Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | P4HTM | Q9NXG6 | 2/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 5/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24454816 | 0.83 | CES2 (0.47) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL18934701 | 0.80 | LMNA (0.56) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL18934700 | 0.78 | CES2 (0.50) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL4336992 | 0.77 | LMNA (0.52) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL6611666 | 0.77 | CES2 (0.59) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL755762 | 0.77 | LMNA (0.63) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL1408599 | 0.77 | CES2 (0.58) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL3032123 | 0.77 | — | — | |
| SCHEMBL24715276 | 0.76 | ALDH1A1 (0.50) | CES2CES1LMNAL3MBTL1P4HTM | |
| SCHEMBL4341948 | 0.75 | ALDH1A1 (0.48) | CES2CES1LMNAL3MBTL1P4HTM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10892426-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-01-12 | — | — | US | disclosed |
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-14 | — | — | US | disclosed |
| US-10256411-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-04-09 | — | — | US | disclosed |
| US-10186672-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-01-22 | — | — | US | disclosed |
| US-9780316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-10-03 | — | — | US | disclosed |
| US-20170194577-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2017-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, LMNB2, RUVBL2 | CES2 718/4885CES1 4139/4885LMNA 1242/4885 |
| US-10892426-B2 | Organic electroluminescent materials and devices | OCIAD2, LMNB2, RUVBL2 | CES2 718/4885CES1 4139/4885LMNA 1242/4885 |
| US-10256411-B2 | Organic electroluminescent materials and devices | OSBP, OSBPL3, OSBPL8 | CES2 670/4885CES1 1525/4885LMNA 3426/4885 |
| US-10186672-B2 | Organic electroluminescent materials and devices | TYR, DDT, EML4 | CES2 2562/4885CES1 4875/4885LMNA 2574/4885 |
| US-20170194577-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TYR, DDT, EML4 | CES2 2562/4885CES1 4875/4885LMNA 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.